A novel telemonitoring device for improving diabetes Control: Protocol and results from a randomized Clinical Trial

Telemedicine and e-Health

Volumn 20, Issue 2, 2014, Pages 109-114

  Pressman, Alice R ^a,b   Kinoshita, Linda ^c   Kirk, Susan ^c   Barbosa, Gina Monraz ^c   Chou, Cathy ^a   Minkoff, Jerome ^c  

^a DIVISION OF RESEARCH   (United States)

^b SUTTER HEALTH   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

diabetes care telemonitoring device trial

Indexed keywords

BLOOD PRESSURE; GLUCOSE; MANAGERS; TELEMETERING EQUIPMENT;

DIABETES PATIENTS; GLYCOSYLATED HEMOGLOBINS; LOW DENSITY LIPOPROTEINS; PARALLEL COMPARISONS; RANDOMIZED CLINICAL TRIALS; RANDOMIZED CONTROLLED TRIAL; TELE-MONITORING; TYPE 2 DIABETES MELLITUS;

TELEMEDICINE;

EID: 84893744252     PISSN: 15305627     EISSN: 15563669     Source Type: Journal    
DOI: 10.1089/tmj.2013.0157     Document Type: Article

References (38)

1. National Center for Chronic Disease Prevention and Health Promotion Diabetes successes and opportunities for population-based prevention and control. Atlanta: Centers for Disease Control and Prevention, 2011.
2. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615.
3. Standards of medical care in diabetes-2013. Diabetes Care 2013;36(Suppl 1): S11-S66.
4. Coca SG, et al. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: Systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med 2012;172:761-769.
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
6. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995;310:83-88.
7. Hemmingsen B, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2011;(6):CD008143.
8. Gerstein HC, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
9. Patel A, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572.
10. Currie CJ, et al. Survival as a function of HbA1c in people with type 2 diabetes: A retrospective cohort study. Lancet 2010;375:481-489.
11. Executive summary: Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S4-S10.
12. Chobanian AV, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-2572.
13. Bakris GL, et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000;36:646-661.
14. American Telemedicine Association. Definition of telemedicine. 2012. Available at www.americantelemed.org/learn (last accessed June 1, 2013).
15. Shea S, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc 2006;13:40-51.
16. Whitlock WL, et al. Telemedicine improved diabetic management. Mil Med 2000;165:579-584.
17. Petitti DB, Contreras R, Dudl J. Randomized trial of fructosamine home monitoring in patients with diabetes. Effect Clin Pract 2001;4:18-23.
18. Koskinen P, et al. Serum fructosamine in the assessment of glycaemic control in diabetes mellitus. Scand J Clin Lab Invest 1987;47:285-292.
19. McDowell J, et al. Validation of the Australian/English version of the Diabetes Management Self-Efficacy Scale. Int J Nurs Pract 2005;11:177-184.
20. Wu V, et al. Development and validation of the Chinese version of the Diabetes Management Self-efficacy Scale. Int J Nurs Stud 2008;45:534-542.
21. Bijl JV, Poelgeest-Eeltink AV, Shortridge-Baggett L. The psychometric properties of the Diabetes Management Self-efficacy Scale for patients with type 2 diabetes mellitus. J Adv Nurs 1999;30:352-359.
22. Shortridge-Baggett LM, van der Bijl JJ. International collaborative research on management self-efficacy in diabetesmellitus. JNY State Nurses Assoc 1996;27:9-14.
23. van der Bijl JJ, Shortridge-Baggett LM. The theory and measurement of the selfefficacy construct. Sch Inq Nurs Pract 2001;15:189-207.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
25. Takahashi PY, et al. A randomized controlled trial of telemonitoring in older adults with multiple health issues to prevent hospitalizations and emergency department visits. Arch Intern Med 2012;172:773-779.
26. Koehler F, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: The Telemedical Interventional Monitoring in Heart Failure Study. Circulation 2011;123:1873-1880.
27. Chaudhry SI, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010;363:2301-2309.
28. Inglis SC, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010;(8):CD007228.
29. Inglis SC, et al. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail 2011;13:1028-1040.
30. Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: A meta-analysis of randomized controlled studies. Am J Hypertens 2011;24:989-998.
31. Pare G, et al. Clinical effects of home telemonitoring in the context of diabetes, asthma, heart failure and hypertension: A systematic review. J Med Internet Res 2010;12:e21.
32. AbuDagga A, Resnick HE, Alwan M. Impact of blood pressure telemonitoring on hypertension outcomes: A literature review. Telemed J E Health 2010;16:830-838.
33. Gurne O, et al. A critical review on telemonitoring in heart failure. Acta Cardiol 2012;67:439-444.
34. Istepanian RS, et al. Evaluation of a mobile phone telemonitoring system for glycaemic control in patients with diabetes. J Telemed Telecare 2009;15:125-128.
35. Stone RA, et al. Active care management supported by home telemonitoring in veterans with type 2 diabetes: The DiaTel randomized controlled trial. Diabetes Care 2010;33:478-484.
36. Stone RA, et al. The Diabetes Telemonitoring Study Extension: An exploratory randomized comparison of alternative interventions to maintain glycemic control after withdrawal of diabetes home telemonitoring. J Am Med Inform Assoc 2012;19:973-979.
37. Polisena J, et al. Home telehealth for diabetes management: A systematic review and meta-analysis. Diabetes Obes Metab 2009;11:913-930.
38. Home telemonitoring for type 2 diabetes: an evidence-based analysis. Ontario Health Technol Assess Ser 2009;9(24):1-38.